Attached files

file filename
EX-21.1 - EXHIBIT 21.1 - IONIS PHARMACEUTICALS INCexhibit21_1.htm
EX-32.1 - EXHIBIT 32.1 - IONIS PHARMACEUTICALS INCexhibit32_1.htm
EX-31.1 - EXHIBIT 31.1 - IONIS PHARMACEUTICALS INCexhibit31_1.htm
EX-10.61 - EXHIBIT 10.61 - IONIS PHARMACEUTICALS INCexhibit10_61.htm
EX-10.59 - EXHIBIT 10.59 - IONIS PHARMACEUTICALS INCexhibit10_59.htm
EX-10.60 - EXHIBIT 10.60 - IONIS PHARMACEUTICALS INCexhibit10_60.htm
EXCEL - IDEA: XBRL DOCUMENT - IONIS PHARMACEUTICALS INCFinancial_Report.xls
10-K - IONIS PHARMACEUTICALS INCform10k.htm
EX-31.2 - EXHIBIT 31.2 - IONIS PHARMACEUTICALS INCexhibit31_2.htm
Exhibit 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 33-55790, 33-72124, 33-75068, 33-96138, 333-71911, 333-90811, 333-38844, 333-71116, 333-71176, 333-89066, 333-89626, 333-128156, 333-130639, 333-134380, 333-141447, 333-151076, 333-188407 and Form S-8 Nos. 33-42356, 33-42970, 33-51236, 33-54840, 33-58450, 33-75150, 33-90780, 333-05825, 333-55683, 333-40336, 333-59296, 333-91572, 333-106859, 333-116962, 333-125911, 333-133853, 333-142777, 333-151996, 333-160269, 333-168674, 333-176136, 333-184788, 333-190408) of Isis Pharmaceuticals, Inc. and in the related Prospectus of our reports dated February 27, 2015, with respect to the consolidated financial statements of Isis Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Isis Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
 
 
 
/s/ ERNST & YOUNG LLP
 
 
San Diego, California
 
February 27, 2015